Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
about
Cancer concepts and principles: primer for the interventional oncologist-part IINew therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma).Gastrinomas: advances in diagnosis and management.Zollinger-Ellison syndrome: classical considerations and current controversies.Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategySurvival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinomaPancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resectionEffect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Comparison study of gastrinomas between gastric and non-gastric origins.Antitumor effects of somatostatin analogs in neuroendocrine tumors.Treatment of Zollinger-Ellison syndrome.The expanding role of somatostatin analogs in the management of neuroendocrine tumors.Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfallsGastrinoma (duodenal and pancreatic).Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.Medical management of pancreatic neuroendocrine tumors.Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Future perspectives on neuroendocrine tumors.Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumorsTreatment options for unresectable neuroendocrine liver metastases.Systemic therapy for advanced pancreatic neuroendocrine tumorsZollinger-Ellison syndrome: recent advances and controversies.Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours.Medical treatment of gastroenteropancreatic neuroendocrine tumors.Management of the hormonal syndrome of neuroendocrine tumors.Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas.Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas.Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?SiRNA-Mediated Down-Regulation of CLIC4 Gene Inhibits Cell Proliferation and Accelerates Cell Apoptosis of Mouse Liver Cancer Hca-F and Hca-P Cells.
P2860
Q27010961-C0C6E7B3-781C-4849-94F6-E90B27E346CFQ30364864-93B82DF0-B112-43BE-9FEE-AE2AA6D25959Q33753449-3A9E7EE7-FCA6-4A2A-A6B6-38DCB7A53BC6Q33782024-605881DA-11A3-4E3C-AF0B-546D6366C5B2Q33801620-C68CAE35-86A1-469E-851B-0996AFB43ED4Q34358058-61D0209B-349E-4CE4-BFD7-98C2E2A7974AQ34390574-BB36BF28-1A1E-4CD6-AEBC-B5E08F205F3CQ34978826-7AB34704-9440-4FD2-926A-877DE52E54E7Q34987688-A4AC560E-B8F0-4D26-9AC1-5F396049B7D8Q35065094-AE6C82B2-D1FD-4FD4-B78B-3EDCD5B457EFQ35550939-E16E1714-E737-4049-8EF4-9B2E25982A10Q35760798-65F5064C-5548-46D2-A08B-9A1AE8F2DE77Q35774521-EA56AF53-2E42-4044-A6BF-312CADA95851Q36051476-9C1F0347-07B3-4E7E-A85F-DA6C1EF23397Q36285347-D176390B-4E81-43A4-B4E6-ABD4302085E9Q36347272-F4E2ED12-4C84-46A5-8129-CC73F0C560B1Q36565495-5AD23137-2274-4692-BFE8-EB3F57CBC8E9Q36582343-FA150ACD-414C-4777-9E41-EFA3C118A2C5Q36741116-FA003AE6-ED8A-4F5C-9675-92701D389D41Q36882123-8C84E983-1E61-44AE-A3EE-1171C3EBDCABQ37009032-410E62A3-A719-449A-9DE3-FA5428C0F96FQ37016985-61093423-6B07-440E-A12B-B76EAC610512Q37056120-048113B7-08B0-47E6-BDEC-D793C85A24B1Q37564373-B5E4C7BA-F8C5-4E30-8BFE-9DCF1C0191B6Q37843819-1D38682C-FFC9-4BAC-A43E-467A31EADF59Q37889407-0B8A1600-1842-4A6D-A19C-F98494C86B00Q38014498-F302B91F-1464-490E-968B-6E38F75AE4D1Q38079854-6ECF1F41-8A18-4C60-97C3-EC696B2116D2Q38150165-5C21EFD1-EA52-4BAF-B9A9-708EF0F92560Q38658730-A250067C-7F3D-4540-A839-11002967A1BFQ38754421-A8D110DF-1BF1-4759-81F8-95312CD1C46FQ39217510-5B7B66A0-D858-4204-9A35-2FF35F77AD01Q39254045-87CFFB5B-9CAA-4DFA-8246-440519DF6FA7Q41832570-D5E99680-1543-473B-8A23-41638CF762A0Q42469904-2C1429AC-B12A-41CF-A6BD-1A1B0A831221Q43121154-1D4E7BD5-E192-4732-B656-CF0BCCA41CB8Q46111876-6BF7588F-5869-4981-BE24-A5F43C856E4FQ46599160-8539B0CB-4538-40AC-BF71-6892A44301EFQ47822235-36CEE1C1-999C-4B85-AE35-A8F9B478BCBDQ48245740-96BC11EB-C7E7-45C6-BC26-B2C1AC0AEE69
P2860
Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prospective study of the antit ...... ressive metastatic gastrinoma.
@en
Prospective study of the antit ...... ressive metastatic gastrinoma.
@nl
type
label
Prospective study of the antit ...... ressive metastatic gastrinoma.
@en
Prospective study of the antit ...... ressive metastatic gastrinoma.
@nl
prefLabel
Prospective study of the antit ...... ressive metastatic gastrinoma.
@en
Prospective study of the antit ...... ressive metastatic gastrinoma.
@nl
P2093
P2860
P356
P1433
P1476
Prospective study of the antit ...... ressive metastatic gastrinoma.
@en
P2093
Adeline Louie
Alaa Abou-Saif
Fathia Gibril
Homayoun Shojamanesh
Jeremiah V Ojeaburu
Robert T Jensen
Showkat Bashir
P2860
P304
P356
10.1002/CNCR.10195
P407
P577
2002-01-01T00:00:00Z